• Blog
  • Diagnostic Testing of STDs Market

    Diagnostic Testing of STDs Market

    Diagnostic Testing of STDs Market
    Report code - SR1769 Delivery - 2 Weeks
    Diagnostic Testing of STDs Market Growth, Size, Share & Forecast Analysis: 2021-2026
    See more...

    Market Insights

    "The global diagnostic testing of STDs market is estimated to grow from USD 148.2 billion in 2020 to USD 258.7 billion by 2026 at a healthy CAGR of 9.9% during the forecast period."

    Want to get a free sample? Register Here

    Sexually transmitted diseases (STDs) are diseases that spread typically through person-to-person sexual contact. Early identification or diagnosis of STDs and partner notification help to halt further transmission. Bacteria, yeast, parasites, and viruses are the prime causes of STDs. Rapid & early diagnosis of STDs is likely to limit the effects as well as the progression of the disease. If the STDs are left untreated, it can result in more serious & long-term health complications. This leads to demand for diagnostic testing of STDs.

    The Diagnostic Testing of STDs market is primarily propelled by a surge in patient awareness regarding education campaigns as well as rising government initiatives boost the market growth. Also, the rising population of having multiple casual sex partners further bolsters diagnostic testing. Moreover, an increasing number of technologically developed products in the field of diagnostics, offer more precise testing results, thus augmenting the market growth during the forecast timeline.

    The outbreak of COVID-19 moderately affected the diagnostic testing of the STD industry. Screening rates for diseases such as gonorrhea and chlamydia plummeted during the COVID-19 pandemic, along with the weekly positivity rates increasing. The researchers found out that testing & screening for sexually transmitted infections had plunged by 63% for men and 59% for women during the early months of the COVID-19 pandemic.

    Diagnostic Testing of STDs Market Report Overview

    Base Year of Study

    2020

    Trend Period

    2015-2019

    CAGR (2021-2026)

    9.9%

    Market Size in 2020

    US$ 148.2 billion

    Market Size in 2026

    US$ 258.7 billion

    Forecast Period

    2021-2026

    Segment’s Analysis

    Diagnostic Test Trends

    "The wound care devices segment accounted for the largest market share."

    Based on diagnostic tests, the diagnostic testing of the STDs market has been classified into culture/isolation of organisms, molecular test, immunology assay, and others. The wound care devices segment accounted for the largest market share in 2020. For diagnosing several STDs, tests such as nucleic acid amplification test (NAAT) is used. It is a molecular test which detects DNA, the genetic material of Chlamydia trachomatis. It is more sensitive & specific than the other chlamydia tests and it can be performed on a vaginal swab, which eliminates the requirement for a pelvic exam in women.

    Regional Insights

    "North America accounted for the largest market share."

    By region, the North America Diagnostic Testing of STDs market accounted the highest share in 2020 and is expected to grow at a robust CAGR during the review period. The Diagnostic Testing of STDs market growth is mainly attributed to strong prevalence of STD's, presence of large number of diagnostic companies, and greater disease awareness.

    The Asia Pacific Diagnostic Testing of STDs market is expected to grow at a healthy CAGR during the review period owing to the rising prevalence of STDs in the underdeveloped countries of Asia Pacific, economic growth, increasing awareness, and increase in the adoption of technologically advanced products proliferated the regional market growth.

    Want to get a free sample? Register Here

    Key Players

    Key players operating in the global Diagnostic Testing of STDs Market are-

    • Siemens Healthcare GmbH (Germany)
    • Abbott Laboratories (US)
    • MedMira Inc (Canada)
    • Qiagen Inc (Netherlands‎)
    • Danaher Corporation (Cephied) (US)
    • F. Hoffmann-La Roche AG (Switzerland)
    • Diasorin S.p.A (Italy)
    • BioMerieux (France)
    • Hologic, Inc (US)
    • Bio-Rad Laboratories, Inc. (US)

    Note: The above list does not necessarily include all the top players in the market.

    Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What deliverables will you get in this report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth analysis of the Diagnostic Testing of STDs Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional and country level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Research Methodology

    This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s diagnostic testing of STDs market realities and future market possibilities for the forecast period. The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate growth strategies to expedite their growth process.

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Sexually Transmitted Diseases (STDs) are diseases, which spreads typically through person-to-person sexual contact. Early identification or diagnosis of STDs and partner notification which helps to halt further transmission. Bacteria, yeast, parasites, and viruses are the prime causes of STD's. Rapid & early diagnosis of STDs is likely to limit the effects as well as a progression of the disease. If the STDs are left untreated, it can result to more serious & long-term health complications. This leads to demand for diagnostic testing of STDs.

    North America accounted for the highest share in 2020 and is expected to grow at a robust CAGR during the review period.

    The diagnostic testing of STDs market is estimated to grow from USD 148.2 billion in 2020 to USD 258.7 billion by 2026 at a healthy CAGR of 9.9% during the forecast period.

    The diagnostic testing of STDs market is primarily propelled by a surge in patient awareness regarding education campaigns as well as rising government initiatives boosts the market growth.